Figure 3 Discussion In this large real-world study, we found that GLP-1RAs are associated with an increased risk of gastrointestinal AEs, which were mainly attributed to liraglutide, dulaglutide, and semaglutide
Individual absorption capacity may also be influenced by digestive health markers, enzyme activity, and microbiome composition, all factors a provider can assess during optimization
This increases the risk of disordered eating or developing an eating disorder. Patients commonly regain weight after they stop taking GLP-1 medications, and a new, albeit small, survey indicates that patients who ceased anti-obesity medication reported consuming more calories
Some may recall actress Clara Peller from Wendys Wheres The Beef? commercials later finding beef in Prego spaghetti sauce, much to the burger chains dismay
What is an opioid
Sigma) following the protocol provided by the manufacturer